• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETEW1313C82E
Medical Device Problem Code Malposition of Device (2616)
Health Effect - Clinical Codes Low Blood Pressure/ Hypotension (1914); Perforation of Vessels (2135)
Date of Event 03/01/2021
Type of Reportable Event Death
Additional Manufacturer Narrative
Concomitant medical products: other relevant device(s) are: product id: etlw1616c93e, serial/lot #: (b)(4), ubd: 31-aug-2022, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Endurant stent grafts were implanted in the patient for the emergency endovascular treatment of a ruptured iliac artery.It was reported during the procedure etew1313c82e and etlw1616c93e were placed quickly in the artery yet the pressure continued to drop.The abdomen was then opened up and it was noted the limb was not properly in the artery as the artery was destroyed.It was reported the cause of the limb not being correctly placed was due to small access vessels.It was reported the patient died one day post procedure.As per the physician, the death was not related to the medtronic devices.
 
Additional Manufacturer Narrative
Additional information received; it was reported the rupture occurred while the device was being removed and was caused by calcified and small vessels.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II ILIAC STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
MDR Report Key11543195
Report Number9612164-2021-01081
Device Sequence Number19574673
Product Code MIH
UDI-Device Identifier00613994991386
UDI-Public00613994991386
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/15/2022
Device Model NumberETEW1313C82E
Device Catalogue NumberETEW1313C82E
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 03/02/2021
Supplement Date Received by Manufacturer03/23/2021
Initial Report FDA Received Date03/22/2021
Supplement Report FDA Received Date04/20/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient Age87 YR
-
-